Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

1.1K
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
1.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

914
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
914
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

80
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
80
Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

622
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
622
Anthelminthic Agents01:15

Anthelminthic Agents

97
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
97

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Psychiatric comorbidities and treatment patterns in epilepsy: A retrospective review from a tertiary neuropsychiatric clinic.

Indian journal of psychiatry·2026
Same author

Mitochondrial dysfunction in schizophrenia and its modulation by atypical antipsychotic drugs: A randomized controlled trial.

Journal of psychopharmacology (Oxford, England)·2026
Same author

Lumateperone as an alternative to clozapine in treatment-resistant schizophrenia: Insights from a quantitative systems pharmacology model.

The Journal of pharmacology and experimental therapeutics·2026
Same author

Null result: Inconvenient, underreported, and indispensable!

Indian journal of pharmacology·2026
Same author

Precision dosing of clozapine: A physiologically based pharmacokinetic/pharmacodynamic model integrating genetic polymorphisms and clinical outcomes.

Journal of psychopharmacology (Oxford, England)·2026
Same author

Augmentation of clozapine with dextromethorphan in treatment-resistant schizophrenia: A randomized, group sequential adaptive design, controlled clinical trial.

Asian journal of psychiatry·2026
Same journal

Autopsy-proven Mirtazapine Withdrawal-induced Mania/Hypomania Associated with Sudden Death.

Journal of pharmacology & pharmacotherapeutics·2018
Same journal

Low-Dose Mirtazapine-Induced Nightmares Necessitating its Discontinuation in a Young Adult Female.

Journal of pharmacology & pharmacotherapeutics·2018
Same journal

Levosulpiride-induced Movement Disorders.

Journal of pharmacology & pharmacotherapeutics·2018
Same journal

Vitamin B<sub>12</sub> Supplementation and Methylcobalamin: Use or Misuse.

Journal of pharmacology & pharmacotherapeutics·2018
Same journal

Learning Pharmacology by Metaphors: A Tale of Beta-blockers.

Journal of pharmacology & pharmacotherapeutics·2018
Same journal

Efficacy and Safety of Oral Diclofenac Sustained release Versus Transdermal Diclofenac Patch in Chronic Musculoskeletal Pain: A Randomized, Open Label Trial.

Journal of pharmacology & pharmacotherapeutics·2018
See all related articles

Related Experiment Video

Updated: Apr 24, 2026

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

865

Metronomic chemotherapy.

Rituparna Maiti1

  • 1Department of Pharmacology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.

Journal of Pharmacology & Pharmacotherapeutics
|September 12, 2014
PubMed
Summary
This summary is machine-generated.

Metronomic chemotherapy offers a novel approach to cancer treatment by frequently administering low-dose chemotherapy to target tumor endothelial cells. This method minimizes adverse effects and chemoresistance, establishing it as a promising multi-targeted therapy.

Keywords:
Anti-angiogenesisconventional chemotherapymetronomic chemotherapytumor dormancy

More Related Videos

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

10.8K
Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
08:57

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on: October 5, 2017

9.8K

Related Experiment Videos

Last Updated: Apr 24, 2026

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

865
Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

10.8K
Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
08:57

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on: October 5, 2017

9.8K

Area of Science:

  • Oncology
  • Pharmacology
  • Cancer Biology

Background:

  • Traditional chemotherapy faces challenges with toxic effects and chemoresistance.
  • Metronomic chemotherapy emerges as an alternative drug administration strategy.

Purpose of the Study:

  • To explore the mechanisms and benefits of metronomic chemotherapy.
  • To establish metronomic chemotherapy as a multi-targeted therapy.

Main Methods:

  • Frequent administration of conventional chemotherapeutic agents at low doses.
  • Targeting activated endothelial cells in tumors.
  • Investigating novel anti-cancer mechanisms beyond angiogenesis inhibition.

Main Results:

  • Metronomic chemotherapy demonstrates minimal adverse effects.
  • Reduced incidence of acquired drug resistance.
  • Emerging evidence supports its role as a multi-targeted therapy.

Conclusions:

  • Metronomic chemotherapy presents a promising strategy with reduced toxicity and resistance.
  • Further research, including pharmacogenomic studies and clinical trials, is crucial for optimizing treatment protocols for various cancer types.